RMD Dec 2024 280.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:19AM EDT. Market open.
Loading interactive chart…
- Zacks
Here's Why Investors Should Buy ResMed (RMD) Stock Now
Investors are optimistic about ResMed's (RMD) potential in digital health and expansion in the international market.
- Zacks
Boston Scientific (BSX) mCRM System Study Outcome Favorable
Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.
- Zacks
Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
© 2024 Yahoo. All rights reserved.